about
Triiodothyronine increases mRNA and protein leptin levels in short time in 3T3-L1 adipocytes by PI3K pathway activationSevere food restriction induces myocardial dysfunction related to SERCA2 activityTriiodothyronine and breast cancer.A comparative genotoxicity study of a supraphysiological dose of triiodothyronine (T₃) in obese rats subjected to either calorie-restricted diet or hyperthyroidism.Thyroid hormone status interferes with estrogen target gene expression in breast cancer samples in menopausal women.Triiodothyronine (T3) induces HIF1A and TGFA expression in MCF7 cells by activating PI3K.Modulation of thyroid hormone receptors, TRα and TRβ, by using different doses of triiodothyronine (T3) at different times.Human breast tumor slices as an alternative approach to cell lines to individualize research for each patient.Roles of the Taql and Bsml vitamin D receptor gene polymorphisms in hospital mortality of burn patients.Administration of physiologic levels of triiodothyronine increases leptin expression in calorie-restricted obese rats, but does not influence weight loss.Lycopene supplementation modulates plasma concentrations and epididymal adipose tissue mRNA of leptin, resistin and IL-6 in diet-induced obese rats.Tamoxifen inhibits transforming growth factor-alpha gene expression in human breast carcinoma samples treated with triiodothyronine.Gene expression of estrogen receptor-alpha in orbital fibroblasts in Graves' ophthalmopathy.Experimental hyperthyroidism decreases gene expression and serum levels of adipokines in obesity.Estrogen-responsive genes overlap with triiodothyronine-responsive genes in a breast carcinoma cell lineMolecular analysis of the Von Hippel-Lindau (VHL) gene in a family with non-syndromic pheochromocytoma: the importance of genetic testingUpregulation of mRNA myocardium calcium handling in rats submitted to exercise and food restriction[Thyroid hormone profile in breast cancer patients in postmenopause]Oncogenic osteomalacia: loss of hypophosphatemia might be the key to avoid misdiagnosisGraves ophthalmopathy: low-dose glucocorticoid increases peroxisome proliferator-activated receptor-gamma gene expression
P50
Q28388841-143A6C2C-2AE2-46FF-A03E-C2407F50245AQ28577981-299C5316-7038-4C1F-A0C2-C471D7B5D715Q34023731-7E501960-E211-4763-AD10-6E50C89B6819Q34611627-267DA633-8C14-4D86-85C7-F4F3D1706A66Q37631648-8E79222C-10FA-4EC9-B552-EF875F186D03Q38776990-144286E0-D497-49B3-A6FA-24078BB1A63EQ39118506-A3905D4E-6778-437A-B18F-2134D2F753A2Q39449501-0C29F53A-0310-4DF3-B62F-F2F8C7BB56DFQ40582267-093C9ABA-19C6-4A83-B36B-867064EE5AFBQ43257388-2C5ACA60-8F5C-405B-B6DE-12CD6A5C4A69Q43500979-B3519FF6-17C2-4F76-B3C9-E1B5ED34F3FCQ46107136-E09FCDCB-87F8-4BB8-A088-C1C07C954708Q54157212-11073DB8-90EC-40A6-8E60-DF378CCD9D79Q55453621-2031B6F5-B4C5-41E8-A1C3-CD736C8D8D58Q59101175-0915322C-18DD-421A-B71D-7BCF3C79543DQ80525979-F5CC7E93-7CB4-45D6-9B53-6D219AAA4B91Q84229397-6A5362A5-7758-4F5F-BED3-4A8091E6BA29Q84568722-737F8BC1-5344-4587-8C6E-F2F2A4B4CEDAQ85847821-99E4C40D-86DF-439F-AD14-B670FBFF766CQ86241832-7D6732DD-9635-46A7-9CBE-550F9D6D04DC
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sandro José Conde
@ast
Sandro José Conde
@en
Sandro José Conde
@es
Sandro José Conde
@nl
Sandro José Conde
@sl
type
label
Sandro José Conde
@ast
Sandro José Conde
@en
Sandro José Conde
@es
Sandro José Conde
@nl
Sandro José Conde
@sl
prefLabel
Sandro José Conde
@ast
Sandro José Conde
@en
Sandro José Conde
@es
Sandro José Conde
@nl
Sandro José Conde
@sl
P106
P21
P31
P496
0000-0003-1876-5418